Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,386
Closed -$173K 877
2022
Q1
$173K Buy
+1,386
New +$184K 0.05% 375
2021
Q4
Sell
-10,387
Closed -$1.52M 933
2021
Q3
$1.52M Buy
10,387
+1,473
+17% +$239K 0.37% 57
2021
Q2
$1.49M Buy
8,914
+8,870
+20,159% +$1.48M 0.34% 62
2021
Q1
$7.13K Buy
44
+43
+4,300% +$6.44K ﹤0.01% 608
2020
Q4
$175 Sell
1
-1,240
-100% -$176K ﹤0.01% 801
2020
Q3
$166K Hold
1,241
0.05% 226
2020
Q2
$162K Buy
+1,241
New +$156K 0.04% 229
2020
Q1
Sell
-4,267
Closed -$641K 728
2019
Q4
$641K Sell
4,267
-4,829
-53% -$676K 0.12% 139
2019
Q3
$1.25M Sell
9,096
-729
-7% -$102K 0.22% 87
2019
Q2
$1.42M Buy
+9,825
New +$1.51M 0.25% 83

Other funds holding MMM

Exane Derivatives's MMM Position: Q2 2022 in Review

Exane Derivatives sold out of 3M (MMM) in Q2 2022, closing a stake of 1,386 shares — an estimated $173K sold.

Exane Derivatives first reported a position in MMM in Q2 2019 and held it in 10 quarters. The position peaked at $1.52M in Q3 2021. 2,185 funds tracked by Wall St. Rank hold MMM as of Q2 2022.

  • Exane Derivatives reported no remaining 3M position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 1,386 3M shares in Q2 2022, an estimated $173K.
  • Exane Derivatives first reported a position in 3M in Q2 2019 and held it in 10 quarters.
  • Exane Derivatives's 3M position peaked at $1.52M in Q3 2021.
  • 2,185 funds tracked by Wall St. Rank held 3M as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.